These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 21069517)
1. An unusual case of allopurinol hypersensitivity syndrome potentiated by intravitreal bevacizumab. Padhy BM; Gupta YK; Shanmugam SP; Bamrolia NR Eur J Clin Pharmacol; 2011 May; 67(5):537-8. PubMed ID: 21069517 [No Abstract] [Full Text] [Related]
2. Angioedema after intravitreal bevacizumab injection. Toklu Y; Sarac O; Berk S; Simsek S Cutan Ocul Toxicol; 2012 Mar; 31(1):85-6. PubMed ID: 22309281 [TBL] [Abstract][Full Text] [Related]
3. Hand eruption after intravenous administration of bevacizumab. Ruiz V; Garcia-Muret MP; Alomar A J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):238-9. PubMed ID: 20477919 [No Abstract] [Full Text] [Related]
4. Allopurinol hypersensitivity. A case report. Stein CM S Afr Med J; 1985 Jun; 67(23):935-6. PubMed ID: 3159106 [TBL] [Abstract][Full Text] [Related]
5. Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity. Shah PK; Morris RJ; Narendran V; Kalpana N Indian J Ophthalmol; 2011; 59(1):73-4. PubMed ID: 21157086 [No Abstract] [Full Text] [Related]
9. An unusual case of hypersensitivity vasculitis probably due to allopurinol. Falco D; Daniels RA; Conklin R J Med Soc N J; 1982 May; 79(5):409-12. PubMed ID: 6954286 [No Abstract] [Full Text] [Related]
10. [Effectivity and safety of bevacizumab intravitreal injections for exudative age-related macular degeneration treatment--6 months observations]. Małgorzata F Klin Oczna; 2010; 112(7-9):213-6. PubMed ID: 21121123 [TBL] [Abstract][Full Text] [Related]
11. Death following allopurinol hypersensitivity syndrome. Hanger HC; Pillans PI N Z Med J; 1994 Jun; 107(979):229. PubMed ID: 8208488 [No Abstract] [Full Text] [Related]